Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $48.5200 (4.93%) ($48.5200 - $48.5900) on Fri. Jul. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.11% (three month average) | RSI | 73 | Latest Price | $48.5200(4.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 11.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(61%) IWC(60%) IBUY(58%) IWM(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.555% in a week (0% probabilities). VIXM(-32%) UUP(-16%) VXX(-12%) TBT(-6%) UNG(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.555% (StdDev 5.11%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $48.64(-0.25%) | 10 Day Moving Average | $48.92(-0.82%) | 20 Day Moving Average | $43.29(12.08%) | To recent high | -15% | To recent low | 54.8% | Market Cap | $3.013b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |